Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) University of Connecticut Health Center |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00249418 |
The purpose of this study is to train therapists to administer contingency management (CM). This project will train up to 42 community-based treatment providers about the rationale for and the specifics of administering CM. Initial training will occur in 2-day workshops, followed by weekly supervision in delivery of CM with test cases. We expect that the majority of therapists will achieve high levels of competence and adherence in administering CM treatment within 3-5 test cases, as measured by ratings of audiotapes. To examine the efficacy of CM, each therapist who achieves adherence and competence in delivering CM will administer standard treatment alone or standard treatment plus CM to substance-abusing outpatients. In the CM condition, patients will have the opportunity to win prizes ranging in value from $1 to $100 for submission of negative samples, and the treatment will be in effect for 12 weeks. In total, up to 200 patients will be randomly assigned to one of the two conditions. A research evaluator will conduct follow-up assessments, scheduled for 3, 6 and 9 months after treatment initiation.
Condition | Intervention |
---|---|
Substance Abuse |
Behavioral: Contingency management |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Training Therapists to Administer Contingency Management-Patient Phase |
Estimated Enrollment: | 200 |
Study Start Date: | January 2004 |
Estimated Study Completion Date: | January 2009 |
Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
For those in drug-free programs, they must have initiated treatment within the past week. For methadone patients, they must be stabilized on a dose of methadone, defined as being on the same dose for at least 30 days and not currently requesting or being considered for a dose modification. Methadone patients must also have submitted at least 30% cocaine positive urine samples in the past 3 months.
Exclusion criteria:
Contact: Ellen M Ciesielski, BA | (860)679-4556 | ciesielski@psychiatry.uchc.edu |
Contact: Sheila Alessi, Ph.D. | 860.679.1849 | alessi@psychiatry.uchc.edu |
United States, Connecticut | |
University of Connecticut Health Center | Recruiting |
Farmington, Connecticut, United States, 06030 2103 | |
Contact: Nancy Petry, Ph.D. 860-679-2593 petry@psychiatry.uchc.edu |
Principal Investigator: | Nancy Petry, Ph.D. | University of Connecticut Health Center |
Responsible Party: | UConn Health Center ( Nancy Petry, Ph.D. ) |
Study ID Numbers: | NIDA-16855-3, R01-16855-3 |
Study First Received: | November 3, 2005 |
Last Updated: | May 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00249418 |
Health Authority: | United States: Federal Government; United States: Institutional Review Board |
Contingency Management Substance Abuse Treatment |
Mental Disorders Substance-Related Disorders Disorders of Environmental Origin |